deltatrials
Completed OBSERVATIONAL NCT00373035

Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy

Biomarkers of Prostate Cancer

Sponsor: National Cancer Institute (NCI)

Conditions Prostate Cancer
Interventions biopsy immunological diagnostic method laboratory biomarker analysis mass spectrometry proteomic profiling ultrasound imaging
Updated 6 times since 2017 Last updated: Jan 17, 2017 Started: Feb 28, 2006 Primary completion: Jul 31, 2006
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Prostate Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Feb 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Wake Forest University Health Sciences
Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations